Clinical Trial Update: Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection [Phase 2, Phase 3]

View source ↗

Summary

Update on Phase 2 and Phase 3 trials evaluating fecal microbiota therapy for recurrent Clostridium difficile infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Fecal microbiota therapy (fecal microbiota transplantation)

Snippet

Sponsor: Queen Elizabeth II Health Sciences Centre | Conditions: Clostridium Difficile Infection | Phase 2, Phase 3 | Status: UNKNOWN